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Abstract
Background: Visceral adipose tissue (VAT) and truncal fat predict cardiometabolic disease. Intervention trials
suggest that saturated fatty acids (SFA), e.g. palmitic acid, promote abdominal and liver fat storage whereas
polyunsaturated fatty acids (PUFA), e.g. linoleic acid, prevent fat accumulation. Such findings require investigation in
population-based studies of older individuals. We aimed to investigate the relationships of serum biomarkers of
PUFA intake as well as serum levels of palmitic acid, with abdominal and total adipose tissue content.
Methods: In a population-based sample of 287 elderly subjects in the PIVUS cohort, we assessed fatty acid
composition in serum cholesterol esters (CE) and phospholipids (PL) by gas chromatography and the amount of
VAT and abdominal subcutaneous (SAT) adipose tissue by magnetic resonance imaging (MRI), liver fat by MR
spectroscopy (MRS), and total body fat, trunk fat and leg fat by dual-energy X-ray absorptiometry (DXA). Insulin
resistance was estimated by HOMA-IR.
Results: VAT and trunk fat showed the strongest correlation with insulin resistance (r = 0.49, P < 0.001). Linoleic acid
in both CE and PL was inversely related to all body fat depots (r = −0.24 to −0.33, P < 0.001) including liver fat
measured in a sub-group (r = −0.26, P < 0.05, n = 73), whereas n-3 PUFA showed weak inverse (18:3n-3) or positive
(20:5n-3) associations. Palmitic acid in CE, but not in PL, was directly correlated with VAT (r = 0.19, P < 0.001) and
trunk fat (r = 0.18, P = 0.003). Overall, the significant associations remained after adjusting for energy intake, height,
alcohol, sex, smoking, education and physical activity. The inverse correlation between linoleic acid and VAT
remained significant after further adjustment for total body fat.
Conclusions: Serum linoleic acid is inversely related to body fat storage including VAT and trunk fat whereas
palmitic acid was less consistently but directly associated, in line with recent feeding studies. Considering the close
link between VAT and insulin resistance, a potential preventive role of plant-based PUFA in VAT accumulation
warrants further study.
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Background
While obesity is associated with metabolic disorders, the
relative accumulation of both visceral adipose tissue
(VAT) and abdominal subcutaneous adipose tissue
(SAT) is probably of greater importance than the total
amount of adipose tissue [1] . In particular, VAT has
been linked with insulin resistance [2–4], although little
is known about factors determining VAT deposition.
The role of diet for body fat distribution is poorly under-
stood, but accumulating data suggest that differences in
dietary fat composition are involved [5–7]. Animal stud-
ies have indicated that diets rich in polyunsaturated fatty
acids (PUFA) result in lower fat accumulation [8–11]
compared with saturated fatty acids (SFA), possibly
through greater fat oxidation compared with long-chain
SFA [12–14]. Furthermore, linoleic acid, 18:2n-6 (LA),
may improve insulin sensitivity [7, 15–19], possibly in
part through a PUFA-dependent reduction of VAT and
liver fat [5, 6]. Compared with PUFA, SFA may also
induce lipogenic enzymes such as stearoyl-CoA desatur-
ase (SCD) [20]. Randomized feeding studies have shown
that LA, the major dietary PUFA, decrease trunk fat
[21], VAT/SAT ratio [6] and abdominal fat [7] compared
with a diet high in SFA. Notably, we recently showed
that high intake of palmitic acid, 16:0 (PA), for 7 weeks
markedly increased VAT, liver fat and total fat accumula-
tion in healthy, young subjects, whereas high intake of
LA caused a several-fold lower accumulation of VAT
and liver fat [5]. It would be intriguing if such short-
term effects could be confirmed in observational
settings, potentially reflecting long-term relationships
between specific fatty acid intake and body fat distribu-
tion. A small study of 24 overweight Japanese men
reported a direct association between VAT thickness and
serum PA, and an inverse association with LA [22]. Fur-
thermore, cross-sectional analyses in a large population-
based sample (n = 3926) observed higher prevalence of
abdominal obesity in subjects with higher serum PA and
lower serum LA [23].
Altered fatty acid desaturase activities may also be
involved in body fat accumulation, e.g. deletion of SCD
activity reduces fat mass in animals [24]. Estimated hep-
atic SCD activity was decreased by PUFA, possibly medi-
ating the reduced fat accumulation [5, 6].
Fatty acid composition in cholesterol esters (CE) is an
objective marker of dietary intake, and intake of PUFA
such as LA in particular is reflected well in serum CE
[25–28] and correlates well with self-reported fatty acid
intake in Swedish [29] and other cohorts [27]. Intake of
major SFA such as PA is also reflected in serum CE, but
to a lesser extent than PUFA due to endogenous synthe-
sis and further elongation [17].
In a population-based sample of elderly individuals we
aimed to investigate the associations between serum
fatty acids, especially those used in feeding trials (i.e. PA
and LA, as well as n-3 PUFA, which are valid dietary
biomarkers), and adipose tissue content assessed by
magnetic resonance imaging (MRI) and dual-energy X-
ray absorptiometry (DXA). Furthermore we examined
associations between body fat distribution with esti-
mated desaturase activities and with insulin resistance,
respectively.
Methods
Subjects participated in the Prospective Investigation of
the Vasculature in Uppsala Seniors (PIVUS) cohort
study. All individuals who were 70 years of age and liv-
ing in Uppsala, Sweden, were invited. Between April
2001 and June 2004, 2,025 subjects were randomly in-
vited within one month of their seventieth birthday in
order to standardize for age, and 1,016 (50.1%) chose to
participate. MRI was performed on 287 randomly se-
lected subjects, which represents the current study
population. All participants gave written informed con-
sent and the study was approved by the regional ethical
review board in Uppsala. Blood samples and anthropo-
metric measurements were taken after an overnight fast.
Body mass index (BMI) was calculated as weight (kg)
divided by height (m) squared. Insulin resistance was
assessed by homeostasis model of assessment insulin
resistance (HOMA-IR) [30].
Assessment of fatty acid composition
Fatty acid composition in serum cholesterol esters (CE)
and phospholipids (PL) were measured by gas chroma-
tography. Serum (0.5 mL) was mixed with 2.5 mL
methanol, 5 mL chloroform (with 0.005% added butyl-
ated hydroxytoluene, BHT) and 7.5 mL NaH2PO4
(0.2 mol/l) and stored at 4 °C overnight for lipid extrac-
tion. The chloroform phase was then removed with a
syringe and evaporated to dryness on a 30 °C heating
block using nitrogen gas. The lipid residue was dissolved
in chloroform and the lipid esters were separated by
thin-layer chromatography (TLC); the adsorbent con-
taining POPOP was used as fluorescent agent. The TLC
plates were eluted at room temperature with the solvent
system petroleum ether/diethyl ether/acetic acid (81:18:1
by volume). The lipid fractions were visualized in UV
light; the spots containing cholesterol esters and phos-
pholipids were scraped off into vials and the lipid esters
were then methylated at 60 °C overnight after addition
of 2 mL H2SO4 (5%) methanol. The fatty acid methyl
esters were extracted into 3 mL petroleum ether (0.005%
BHT) after addition of 1.5 mL distilled water. The
phases were separated after thorough mixing and centri-
fugation at 1500 g for 10 min. The petroleum ether
phase was pipetted off and the solvent was evaporated
under nitrogen gas on a 30 °C heating block. The fatty
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acid methyl esters were dissolved in 120 μL hexane and
placed in vials. The fatty acid methyl esters were
separated by gas–liquid chromatography on a 30-m glass
capillary column coated with Thermo TR-FAME
(Thermo Electron Corporation, USA) with helium gas as
a carrier gas. An Agilent Technologies system consisting
of model GLC 6890 N, autosampler 7683 and Agilent
ChemStation was used. The temperature was pro-
grammed to 150–260 °C. The fatty acids were identified
by comparing each peak’s retention time with fatty acid
methyl ester standards Nu Check Prep (Elysian, MN,
USA). In 20 replicates, the CV% for included fatty acids
was 0.37–2.49 in CE and 0.52–1.27 in PL. Fatty acids are
presented as the relative sum of the fatty acids analysed.
Desaturase activities were estimated as product-to-
precursor ratios of individual fatty acids as follows: SCD;
16:1n-7/16:0, delta-5 desaturase; 20:4n–6/20:3n-6 and
delta-6 desaturase; 18:3n–6/18:2n–6.
Assessment of body fat content and distribution
VAT and SAT were measured by MRI. MRI was
performed using a single axial 10 mm slice at the L4-L5
interface. VAT and SAT areas (cm2) were assessed using
the software package ImageJ by manual contouring of
the two tissues. The methodology has previously been
described [31]. Based on repeated measurements in 22
of the subjects, the CVs of VAT and SAT were found to
be 5.9 and 3.4%, respectively. Total body fat, trunk fat
and leg fat were measured by DXA. By triple measure-
ments in 15 subjects, the precision error of the DXA
measurements (DPX Prodigy, Lunar corp., Madison, WI,
USA) was 1.5% for total fat mass. In a subsample of n =
73 subjects from the whole PIVUS cohort, liver fat was
measured using a single volume 1H-spectroscopy acqui-
sition that was performed with and without water-
suppression (WS) during shallow breathing. A volume of
interest 3x3x3 cm was positioned in the right lobe of the
liver and data were obtained using TR/TE = 3000/30 ms
with 16 excitations without WS and 64 with WS. A sin-
gle volume 1H-spectroscopy acquisition was performed
with and without WS. All spectroscopy analyses were
performed with the MRUI software (version 2.2) using
water as an internal reference giving intrahepatocellular
lipid levels as output in %. DXA and MRI measurements
were performed in the non-fasted state, on average two
years after the baseline investigation at age 70.
Assessment of physical activity and dietary intake
Physical activity was assessed by asking the participant
how many times per week he/she performed light (e.g.
walking, gardening) and hard exercise (e.g. running,
swimming) for at least 30 min. A 7-day pre-coded diet-
ary record was used to assess energy intake.
Statistical analyses
The distribution of the variables was examined by the
Shapiro-Wilk W test. To attain normal distribution,
20:5n-3 (EPA), SCD, delta-6 desaturase, SAT, leg fat,
VAT and HOMA-IR were log-transformed. The correl-
ation between serum fatty acids and adipose tissue con-
tent was investigated by Pearson’s correlation analysis.
The Benjamini-Hochberg procedure was used to correct
for multiple comparisons. Multiple regression analyses
were performed with energy intake, height, alcohol
intake, sex, smoking, education and physical activity as
covariates. Collinearity among included covariates was
assessed by the variance inflation factor (VIF). A p-value
<0.05 was considered statistically significant. Based on
the current sample size, we had the ability to detect cor-
relations stronger than ~0.16 with α = 0.05 and β = 0.80
(R code: pwr.r.test(n = 287, r= , sig.level = 0.05, power




As a group, this elderly population was overweight but
generally healthy (Table 1). Men (n = 148, 52%) and
women (n = 139, 48%) were equally represented in the
population. Based on the pre-coded dietary record, sub-
jects had an energy intake of 1887 ± 467 kcal/day (energy
percent from protein, carbohydrates, fat and alcohol
were 16.3, 48.9, 31.1 and 2.0, respectively). The median
number of sessions (30 min) of light exercise per week
was 3 (IQR 2 to 6) and the median number of sessions
(30 min) of hard exercise per week was 0 (IQR 0 to 1).
Serum fatty acids, body fat distribution and liver fat
In serum cholesterol esters, PA was directly associated
with VAT, trunk fat, total fat and the trunk-to-leg fat
ratio, but not with SAT or percent body fat (Fig. 1a).
Conversely, LA was inversely related to SAT, VAT, trunk
fat, leg fat, total fat and percent body fat. The vegetable
n-3 PUFA 18:3n-3 (ALA) was negatively associated with
VAT, trunk fat and total fat, whereas the marine n-3
PUFAs 20:5n-3 (EPA) and 22:6n-3 (DHA) were posi-
tively correlated with fat depots. Importantly, when the
correlations between EPA and DHA with fat depots were
adjusted for LA, none of the correlations remained sta-
tistically significant (Table 2). In the subsample with liver
fat measurement, LA was inversely associated with liver
fat content (rho = −0.26, P = 0.028). The majority of
correlations remained significant after correction for
multiple testing with false discovery rate (FDR) set at
5%, and all correlations were significant at FDR 7%.
Most associations remained significant in the multivari-
ate model (Table 3). When comparing subjects in the
extreme deciles of plasma LA, the differences in total
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fat, SAT and VAT were 9 kg, 62 cm2 and 52 cm2,
respectively. Overall, the significant associations did not
seem to be clearly sex-specific, although the correlation
between PA and SAT was stronger in men than in
women, and the association between delta-5 desaturase
activity index and all fat depots were stronger in women
than in men (data not shown).
The positive associations between PA and VAT and
trunk fat remained statistically significant after adjust-
ment for total body fat, as did the negative association
between LA and VAT (data not shown). However, the
associations for PA were lost when all covariates were
included in the model, but the negative association be-
tween LA and VAT still remained statistically significant
(data not shown).
In serum phospholipids, the overall pattern of associa-
tions was similar to that for cholesterol esters (Fig. 1b),
but associations were stronger for LA and ALA but
weaker for PA, EPA and DHA. In the multivariate model
results were generally similar to that for cholesterol es-
ters (Table 4), but most apparently so for LA, ALA, SCD
and D5D, whereas results for PA and D6D lost
significance.
Desaturation indices and body fat distribution
SCD activity index in serum CE was positively associated
with SAT, trunk fat, leg fat and total fat content, but not
with VAT (Fig. 1a). Delta-6 desaturase activity index was
positively associated with SAT, VAT, trunk fat, leg fat
and total fat. Conversely, delta-5 desaturase activity
index was inversely associated with all fat depots. Results
were similar for serum phospholipids although slightly
attenuated (Fig. 1b). Many of the associations remained
significant in the multivariate model (Tables 3 and 4).
Insulin resistance in relation to body fat and fatty acids
Of all adipose tissue depots, VAT and trunk fat clearly
showed the strongest association with insulin resistance
(r = 0.49, P < 0.001) for both, although SAT (r = 0.31, P <
0.001), leg fat (r = 0.24, P < 0.001), trunk-to-leg fat ratio
(r = 0.27, P < 0.001), percent body fat (r = 0.23, P < 0.001)
and total body fat (r = 0.43, P < 0.001) were also signifi-
cantly associated (Fig. 1a).
PA was directly associated (r = 0.20, P < 0.001) with in-
sulin resistance. Weaker but significant inverse associa-
tions were observed for LA (r = −0.13, P = 0.02) and
delta-5 desaturase (r = −0.12, P = 0.04).
Discussion
Considering the close association between VAT and
insulin resistance, the role of fatty acids as potential
modulators of abdominal fat distribution is of interest.
In this community-based study we observed that serum
PA, partly reflecting dietary intake, was directly associ-
ated with VAT volume, whereas serum LA, mainly
reflecting dietary n-6 PUFA intake, was inversely associ-
ated with VAT, trunk fat, SAT, leg fat, total body fat and
percent body fat. Notably, the inverse link between LA
and VAT was independent of total body fat, potentially
suggesting a rather specific influence of LA on VAT
accumulation. Furthermore, LA was inversely associated
with liver fat content in a smaller subsample. These
results strongly accord with animal studies [8–11], and a
double-blinded trial in healthy adults showing that high
intake of PA for 7 weeks promotes VAT accumulation,
whereas LA prevents VAT, liver- and body fat accumula-
tion [5] instead. This study provides novel evidence that
fatty acid-dependent effects on VAT accumulation may
also occur long-term, adding to the similar findings in
short-term trials. Serum fatty acids in CE partly reflect
average intake over the last days to weeks [25, 26, 28]
but have shown to be rather stable in Swedish middle-
aged and elderly individuals, even over decades [32].
Thus, the present relationships could reflect distinct
long-term effects of SFA and PUFA on body fat
Table 1 Baseline characteristics
Women/Men (%) 48/52
BMI (kg/m2) 26.8 ± 4.1
Visceral Adipose Tissue (cm2) 96.2 (64.9 to 138.8)
Subcutaneous Adipose Tissue (cm2) 208.8 (151.3 to 283.2)
Total Body Fat (kg) 25.1 ± 8.5
Trunk Fat (kg) 13.8 ± 5.0
Leg Fat (kg) 7.6 (5.4 to 9.7)
Waist circumference (cm) 90.7 ± 11.1
Waist/hip ratio 0.9 ± 0.1
Glucose (mM) 5.0 (4.6 to 5.5)
Insulin (pM) 50.0 (36.1 to 72.9)
Insulin resistance (HOMA-IR) 1.6 (1.1 to 2.5)
Systolic Blood Pressure (mmHg) 146 ± 19
Diastolic Blood Pressure (mmHg) 69 ± 8
Total cholesterol (mM) 5.4 ± 1.0
HDL cholesterol (mM) 1.5 ± 0.4
LDL cholesterol (mM) 3.3 ± 0.8
Triacylglycerols (mM) 1.2 (0.9 to 1.6)
Serum fatty acids (CE)a
16:0 (PA) (%) 12.0 ± 0.8
18:2n-6 (LA) (%) 47.6 ± 4.2
18:3n-3 (ALA) (%) 0.9 ± 0.2
20:5n-3 (EPA) (%) 2.1 (1.6 to 2.9)
22:6n-3 (DHA) (%) 1.0 ± 0.3
Data are presented as mean (SD) or median (IQR).aData are percentage of the
total fatty acids analysed. Triacylglycerols, total cholesterol, HDL cholesterol
and insulin were analyzed in serum (LDL cholesterol was calculated according
to the Friedewalds formula). Glucose was analysed in plasma
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accumulation. Moreover, the associations may translate
to noteworthy effects as supported by several feeding
trials [5, 7, 12]. If comparing subjects in the extreme
deciles of serum LA, the differences were as much as
9 kg for total body fat, 62 cm2 for VAT, and 52 cm2 for
SAT, respectively. These results also accord with a 5-
week randomized study showing that increased dietary
PUFA (mainly LA) reduced abdominal SAT compared
with dietary SFA (mainly PA) [7]. Furthermore, a con-
trolled study showed that LA-rich vegetable oil reduced
trunk adipose mass in women with type 2 diabetes [21],
and a randomized study in obese subjects showed re-
duced VAT/SAT ratio after iso-caloric feeding of LA
from sunflower oil versus PA mainly from butter [6].
The current diverse associations between PA and LA
with body fat and VAT accord with a small Japanese
study of men [22], and with three Scandinavian cohorts
reporting inverse relations between LA and BMI, waist
circumference and total fat mass [23, 33, 34], but not
with a small French study reporting direct associations
between LA with BMI and total body fat [35].
The mechanisms behind these observations are un-
clear, but we recently suggested that SFA and PUFA
have diverse effects on certain genes involved in energy
dissipation and fat storage, such as aldehyde dehydro-
genase 1 family member A1 (ALDH1A1), which was
downregulated by LA [5]. It has also been shown that
dietary long-chain SFAs (e.g. PA) have slower oxidation
[36, 37], and an increase in dietary PA decreased fat oxi-
dation and energy expenditure compared to unsaturated
fat [12]. Increased intake of PA over PUFA would thus
be expected to increase body fat accumulation over time,
as shown in animals [38–40] and humans during 4–7
weeks [6, 14]. An obesity-promoting effect of PA might
also be mediated by lower diet-induced thermogenesis
[38, 41]. In the present study, PA was positively associ-
ated with VAT and total fat volume, but not SAT. This
finding accords with our interventional data showing
that high intake of PA caused a significant increase in
VAT, but not abdominal SAT [5]. Since a significant pro-
portion of PA is desaturated by SCD, the present direct
association between estimated hepatic SCD activity and
increased SAT, but not VAT, might reflect a protection
against a PA-induced enlargement of VAT. In the
present observational study, PA in serum CE presumably
mainly reflects relative PA content in the liver that is
partly derived from dietary PA, but possibly also from de
novo lipogenesis during low-fat/high sugar intakes [6]. It
A
B
Fig. 1 Correlations between serum fatty acids and desaturase indices in serum cholesterol esters (a) and serum phospholipids (b) and adipose
tissue depots. Bars are Pearson correlation coefficient (r). The correlation coefficient is given as a number beside the bar for all significant
correlations (P < 0.05). Abbreviations: PA, palmitic acid; LA, linoleic acid; ALA, alpha-linoleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic
acid; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; SCD, stearoyl-CoA desaturase; D5D, delta-5 desaturase; D6D, delta-6 desaturase;
HOMA, homeostasis model of assessment insulin resistance
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should, however, be noted that low fat intakes (<30%E)
and high carbohydrate diets were rare among Swedish
elderly men 15 years ago, when the data were collected;
thus, the contributing role of de novo lipogenesis under
such conditions is likely to have a minor determining
role of serum PA proportions [42]. Due to the uncer-
tainty about serum PA as a dietary marker of PA intake,
the results regarding this fatty acid should be interpreted
cautiously. Additionally, the results for PA were not con-
sistent between the two fractions used (CE and PL)
whereas LA and ALA, which are better dietary bio-
markers, were highly consistent between fractions.
The finding that the main PUFA in the diet and in
serum lipids, LA, showed negative associations with
VAT, trunk fat, liver fat, SAT, leg fat and total body fat
may be due to decreased storage rates of PUFA, and a
higher oxidation rate compared with PA [36]. PUFA,
such as LA, could also counteract lipogenesis by sup-
pressing lipogenic enzymes [43] and transcription factors
[44]. The effects of LA on VAT could potentially be
mediated in part through the corticoid system as has
been recently suggested [45]. The observation that the
estimated SCD activity was directly correlated with SAT
and total body fat, but not VAT (although with trunk
fat), is partly congruent with previous observational
studies in elderly or middle-aged subjects, showing posi-
tive associations with fat mass and obesity [23, 33, 34],
VAT thickness [22] and to obesity-related diseases [16,
46–48]. Currently, delta-6 desaturase activity was posi-
tively associated, whereas delta-5 desaturase activity was
inversely associated with all adipose tissue depots, a pat-
tern consistently observed in insulin resistant states and
obesity [18, 23, 33, 46].
Surprisingly, the marine n-3 PUFAs EPA and DHA
were both positively associated with body fat depots,
which is in stark contrast to what has been shown
experimentally. These present associations are most
likely due to the opposite relationship between the pro-
portions of n-6 and n-3 PUFA. Because they share the
same set of enzymes for elongation, high levels of either
n-6 or n-3 tends to suppress the other. This interpret-
ation is supported by the fact that all associations
between EPA and DHA with fat depots were lost when
adjusted for LA. Although fatty acid composition is pre-
sented in relative proportions, we believe it is justified to
adjust the associations with EPA and DHA for LA due
to the abovementioned biological relationship, and
because EPA and DHA does not share dietary sources of
intake with LA. Failure to consider this may introduce
spurious associations.
Notably, VAT (and trunk fat) was the adipose tissue
depot most closely associated with insulin resistance (esti-
mated by HOMA-IR), suggesting that diverse influences
of fatty acids on VAT may be relevant for metabolic
health. Excess VAT could be causally connected to insulin
resistance, but might also be a marker of inadequate abil-
ity to store excess energy in SAT [49, 50].
Strengths of this study include the population-based
sample, that all subjects were of a similar age, and the
fact that both exposure and outcomes were assessed
with reliable techniques, i.e. gas chromatography was
used for assessing serum fatty acids (avoiding bias of
self-reported intake) and MRI and DXA for determining
body fat content. Based on the current sample size, we
had statistical ability to detect the majority (~75%) of all
significant correlations. Correcting for multiple compari-
sons yielded similar results and did not alter the inter-
pretation. Collinearity among covariates in the multiple
regression models was not a cause for concern as the
maximum VIF value was 2.5 (VIF <10 is generally
accepted as low collinearity). The main weakness is the
cross-sectional design, thus excluding information about
causality. The relatively long lag-time between the MRI
measurements and blood sampling may introduce minor
errors for some individuals, but is unlikely to alter the
results on a group level. Although many of the associa-
tions were significant, many of the fatty acids only
explained a small degree of the variance in the different
Table 2 Multiple regression analyses between EPA and DHA























SAT, abdominal subcutaneous adipose tissue; VAT, visceral adipose tissue; EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid
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body fat depots, implying that other factors (e.g. energy
intake) are of greater importance in determining the size
of the adipose depots. Thus, the overall pattern of asso-
ciations are the most relevant in this study, but it is not
unlikely that even a relatively modest effect of relatively
higher LA intake on body fat distribution could have an
impact on metabolic health in a long-term perspective.
Such speculation is supported by several trials showing
that increasing dietary LA compared with PA is less
obesogenic [5, 7, 12].
Whether different types of dietary fat can modulate
total body fat content or adipose tissue distribution in
humans is important for public health, and the mecha-
nisms warrant further study. Although the results are in
line with previous interventional data including younger
subjects, the observed associations need to be confirmed
Table 3 Fatty acids and desaturases in cholesterol esters in relation to body fat depots
PA LA ALA ln EPA DHA ln SCD D5D ln D6D
ln SAT
β 0.08 −0.03 −0.3 0.12 0.18 0.35 −0.04 0.21
P 0.04 <0.01 0.03 0.06 0.10 <0.01 <0.01 <0.01
R2 0.21 0.26 0.22 0.21 0.21 0.24 0.23 0.24
pR2 0.002 0.07 0.003 0.01 0.01 0.08 0.05 0.05
ln VAT
β 0.12 −0.04 −0.4 0.29 0.39 0.24 −0.05 0.34
P 0.02 <0.01 0.03 <0.01 <0.01 0.07 <0.01 <0.01
R2 0.18 0.24 0.18 0.20 0.19 0.17 0.19 0.22
pR2 0.04 0.07 0.01 0.02 0.02 0.004 0.05 0.06
Total fat, g
β 1645.9 −581.7 −7598.1 2582.7 3917.5 5955.6 −663.6 4001.2
P 0.03 <0.01 <0.01 0.03 <0.05 <0.01 0.01 <0.01
R2 0.17 0.23 0.19 0.17 0.17 0.19 0.18 0.20
pR2 0.02 0.09 0.02 0.02 0.02 0.06 0.03 0.06
Total fat, %
β 0.95 −0.43 −5.87 2.44 3.10 5.07 −0.58 3.81
P 0.11 <0.01 <0.01 <0.01 0.05 <0.01 <0.01 <0.01
R2 0.43 0.46 0.44 0.44 0.43 0.45 0.44 0.46
pR2 0.002 0.05 0.002 0.01 0.01 0.11 0.04 0.08
Trunk fat, g
β 942.0 −338.4 −4356.4 1629.9 2615.1 3004.4 −487.8 2429.9
P 0.03 <0.01 <0.01 0.02 0.03 <0.01 <0.01 <0.01
R2 0.16 0.21 0.18 0.17 0.17 0.17 0.18 0.20
pR2 0.03 0.08 0.03 0.02 0.02 0.02 0.04 0.05
ln Leg fat
β 0.07 −0.02 −0.31 0.08 0.11 0.30 −0.02 0.14
P 0.03 <0.01 <0.01 0.10 0.20 <0.01 0.15 <0.01
R2 0.33 0.37 0.34 0.33 0.32 0.36 0.32 0.34
pR2 0.001 0.06 0.01 0.007 0.008 0.10 0.02 0.05
Trunk/Leg fat
β 0.05 −0.01 −0.03 0.18 0.28 −0.08 −0.04 0.16
P 0.26 0.10 0.86 <0.01 0.02 0.46 <0.01 0.01
R2 0.45 0.45 0.45 0.46 0.46 0.45 0.46 0.46
pR2 0.04 0.003 0.002 0.01 0.004 0.03 0.005 0.005
SAT, abdominal subcutaneous adipose tissue; VAT, visceral adipose tissue; SCD1, stearoyl-CoA desaturase; D5D, delta-5 desaturase; D6D, delta-6 desaturase; PA,
palmitic acid; LA, linoleic acid; ALA, alpha-linoleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; pR2, partial R2
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in other populations and age groups before being extrap-
olated to the general population.
Conclusions
The current findings are in accordance with recent data
from randomized trials [5] and show that LA, primarily
reflecting dietary n-6 PUFA intake, was negatively asso-
ciated with VAT and SAT volumes, as well as with total
body fat, trunk fat, leg fat and percent body fat. These
results are also of metabolic interest since VAT and
trunk fat were the depots most strongly associated with
insulin resistance in this population, and visceral obesity
predisposes individuals to cardiometabolic disease. Thus,
the potential role of dietary fat quality in preventing
excess VAT accumulation and insulin resistance in differ-
ent populations warrants further investigation.
Table 4 Fatty acids and desaturases in phospholipids in relation to body fat depots
PA LA ALA ln EPA DHA ln SCD D5D ln D6D
ln SAT
β 0.02 −0.05 −1.06 0.09 0.03 0.25 −0.11 0.03
P 0.42 <0.01 <0.01 0.19 0.24 0.01 <0.01 0.81
R2 0.20 0.26 0.24 0.20 0.20 0.22 0.22 0.27
pR2 0.0003 0.09 0.02 0.006 0.01 0.07 0.04 0.02
ln VAT
β 0.006 −0.08 −1.57 0.23 0.07 0.12 −0.17 0.02
P 0.85 <0.01 <0.01 <0.01 0.02 0.34 <0.01 0.89
R2 0.17 0.28 0.23 0.19 0.18 0.17 0.20 0.18
pR2 0.0002 0.08 0.05 0.01 0.009 0.00002 0.04 0.002
Total fat, g
β 34.1 −1063.6 −23269.7 1939.3 605.1 3871.2 −1826.9 331.9
P 0.94 <0.01 <0.01 0.12 0.17 0.04 0.02 0.88
R2 0.15 0.24 0.22 0.16 0.16 0.17 0.17 0.27
pR2 0.0008 0.11 0.05 0.007 0.008 0.04 0.04 0.008
Total fat, %
β −0.10 −0.87 −19.4 2.06 0.56 3.25 −1.57 −0.32
P 0.79 <0.01 <0.01 0.04 0.12 0.03 0.01 0.85
R2 0.42 0.48 0.47 0.43 0.42 0.43 0.43 0.52
pR2 0.002 0.09 0.02 0.009 0.007 0.11 0.05 0.02
Trunk fat
β −4.55 −639.6 −14518.5 1139.1 435.0 1667.6 −1325.6 220.7
P 0.99 <0.01 <0.01 0.12 0.10 0.13 <0.01 0.86
R2 0.15 0.24 0.22 0.16 0.16 0.16 0.18 0.20
pR2 0.0004 0.09 0.07 0.007 0.007 0.007 0.03 0.004
ln Leg fat
β 0.005 −0.04 −0.78 0.07 0.01 0.22 −0.05 0.02
P 0.82 <0.01 <0.01 0.17 0.60 <0.01 0.17 0.84
R2 0.31 0.37 0.35 0.32 0.31 0.34 0.32 0.41
pR2 0.00004 0.08 0.02 0.004 0.005 0.10 0.03 0.01
Trunk/Leg fat
β −0.003 −0.04 −0.89 0.14 0.07 −0.11 −0.11 0.02
P 0.92 <0.01 <0.01 0.06 <0.01 0.31 0.02 0.90
R2 0.46 0.48 0.47 0.47 0.47 0.46 0.47 0.44
pR2 0.0003 0.004 0.02 0.005 0.002 0.06 0.0007 0.006
SAT, abdominal subcutaneous adipose tissue; VAT, visceral adipose tissue; SCD1, stearoyl-CoA desaturase; D5D, delta-5 desaturase; D6D, delta-6 desaturase; PA,
palmitic acid; LA, linoleic acid; ALA, alpha-linoleic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; pR2, partial R2
Multiple regression analyses with energy intake, height, alcohol intake, sex, smoking, education and physical activity as covariates
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